- Home
- / Lonza Biologics UK
Lonza Biologics UK
Revenue
£246.3 M
FY, 2020
Lonza Biologics UK Summary
Company Summary
- Overview
- Lonza Biologics UK is a company engaged in mammalian biopharmaceutical development and manufacturing. It focuses on therapeutic grade monoclonal antibodies and recombinant proteins.
- Type
- Subsidiary
- Status
- Active
- Founded
- 1992
- HQ
- Slough, GB | view all locations
Table of Contents
LocationsView all
1 location detected
Slough, England HQ
United Kingdom
228 Bath Rd
Lonza Biologics UK Financials
Summary Financials
- Revenue (FY, 2020)
- £246.3M
- Gross profit (FY, 2020)
- £80.1M
- Net income (FY, 2020)
- £52.1M
- Cash (FY, 2020)
- £4.5M
- EBIT (FY, 2020)
- £59.3M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026